Skip to main content

Grafa News and Videos — Page 1473

Latest

Grafa

Medicus Pharma seeks FDA orphan drug status for novel microneedle skin cancer therapy

Medicus Pharma (NASDAQ:MDCX), a clinical-stage biopharmaceutical company, announced today that it has submitted an application for Orphan Drug Designation (ODD) to the U.S. Food and Drug Administration (FDA) for its flagship candidate, SkinJect (D-MNA).

Read more: Medicus Pharma seeks FDA orphan drug status for novel microneedle skin cancer therapy

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift